Fusion Antibodies plc
FAB.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £252 | £359 | £439 | £1,199 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £868 | £332 | £762 | £557 |
| Inventory | £272 | £269 | £230 | £460 |
| Other Curr. Assets | £0 | £300 | £0 | £46 |
| Total Curr. Assets | £1,392 | £1,260 | £1,431 | £2,262 |
| Property Plant & Equip (Net) | £420 | £63 | £97 | £158 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £420 | £63 | £97 | £158 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,812 | £1,323 | £1,528 | £2,420 |
| Liabilities | – | – | – | – |
| Payables | £667 | £372 | £417 | £283 |
| Short-Term Debt | £105 | £40 | £46 | £40 |
| Tax Payable | £0 | £0 | £0 | £43 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £0 | £211 | -£23 | £218 |
| Total Curr. Liab. | £772 | £623 | £440 | £584 |
| LT Debt | £283 | £0 | £9 | £23 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £31 | £31 | £20 | £20 |
| Total NC Liab. | £314 | £31 | £29 | £43 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £283 | £20 | £32 | £43 |
| Total Liabilities | £1,086 | £654 | £469 | £627 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £4,534 | £4,197 | £3,815 | £3,815 |
| Retained Earnings | -£11,979 | -£11,467 | -£10,499 | -£9,765 |
| AOCI | £0 | £0 | £0 | £0 |
| Other Equity | £8,171 | £7,939 | £7,743 | £7,743 |
| Total Equity | £726 | £669 | £1,059 | £1,793 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1,812 | £1,323 | £1,528 | £2,420 |
| Net Debt | £136 | -£319 | -£384 | -£1,136 |